Form D — NBO Pharma Inc.
0002103906-26-000002 · filed Nov 9, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06c
- Reported offering amount
- $7,000,000
- Reported amount sold
- $238,000
- Minimum investment
- $0
- Investors
- 5
- Sales commission
- $960,000
- Finders' fees
- $0
Issuer
- Name
- NBO Pharma Inc.
- CIK
- 2103906
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 64 QUARRY LANE
BEDFORD, NY 10506 - Phone
- 914-645-1130
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Fredric David Price · Executive OfficerBedford, NY Find on LinkedIn ↗
-
Robert Friedman · DirectorBedford, NY Find on LinkedIn ↗
-
Colin Foster · DirectorBedford, NY Find on LinkedIn ↗
-
Bard Geesaman · DirectorBedford, NY Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗